Back to companies

Dicerna Pharmaceuticals Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

View up-to-date information on Dicerna Pharmaceuticals Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
US20230392148A1 Application Reducing beta-catenin expression to potentiate immunotherapy C12N15/113; C12N2310/14; C12N2310/532; C12N2310/533; C12N2320/31; C12N2320/32; A61K39/39541; A61K47/6911; A61K9/5123; A61K9/5146; A61P35/00; A61P35/02 December 07, 2023
EP4284933A1 Application Zusammensetzungen und verfahren zur hemmung der genexpression im zentralnervensystem C12N15/111; C12N15/1137; C12N2310/3125; C12N2310/315; C12N2310/351; C12N2310/3515; C12N2320/32; C12Y102/01003; A61K47/54; A61K47/542; A61K47/543 December 06, 2023
CN117120613A Application 用于调节pnpla3表达的组合物和方法 C12N2310/14; C12N2310/322; C12N2310/351; C12N15/1137; C12P19/34; A61K31/7125; C12N2310/531; C12N2310/32; C12N2310/346; C12N2310/321; C12N2310/3515; C07H21/02; C12N2310/315 November 24, 2023
US20230374522A1 Application Compositions and methods for modulating scap activity C12N15/1138; C12N2310/14; C12N2310/312; C12N2310/3125; C12N2310/315; C12N2310/321; C12N2310/351; C12N2310/3521; C12N2310/531 November 23, 2023
JP2023548658A Application グリア細胞へのオリゴヌクレオチドの選択的送達 C12N15/113; C12N2310/14; C12N2310/3125; C12N2310/315; C12N2310/321; C12N2310/322; C12N2310/351; C12N2320/32; C12N2503/02 November 20, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Register your interest

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer